Clearance of folliculotropic and tumor mycosis fungoides with topical 5% imiquimod

doi:10.1016/j.jdcr.2015.08.007

Case Reports

. 2015 Sep 27;1(6):348-50.

doi: 10.1016/j.jdcr.2015.08.007. eCollection 2015 Nov.

Clearance of folliculotropic and tumor mycosis fungoides with topical 5% imiquimod

Matthew C Gordon¹, Jason C Sluzevich¹, Anokhi Jambusaria-Pahlajani¹

Affiliations

PMID: 27051776
PMCID: PMC4809372
DOI: 10.1016/j.jdcr.2015.08.007

Case Reports

Clearance of folliculotropic and tumor mycosis fungoides with topical 5% imiquimod

Matthew C Gordon et al. JAAD Case Rep. 2015.

. 2015 Sep 27;1(6):348-50.

doi: 10.1016/j.jdcr.2015.08.007. eCollection 2015 Nov.

Authors

Matthew C Gordon¹, Jason C Sluzevich¹, Anokhi Jambusaria-Pahlajani¹

Affiliation

¹ Department of Dermatology, Mayo Clinic, Jacksonville, Florida.

PMID: 27051776
PMCID: PMC4809372
DOI: 10.1016/j.jdcr.2015.08.007

No abstract available

Keywords: MF, mycosis fungoides; cutaneous T-cell lymphoma; folliculotropic; imiquimod; mycosis fungoides.

PubMed Disclaimer

Figures

**Fig 1**
A, Patient 1 with infiltrated plaques of the left upper and lower eyelid and right nasal sidewall with variable alopecia. B, Same patient 1 year later after 6 months of topical imiquimod. Subtle hypopigmentation in areas of prior involvement is present.

**Fig 2**
A, Patient 2 with indurated eroded plaque of the right ankle with new-onset tumor. B, Same patient after 2 months of topical imiquimod.

See this image and copyright information in PMC

Cited by

Revisiting Imiquimod for Treatment of Folliculotropic Mycosis Fungoides: A Case Report and Review of the Literature.
Shalabi D, Vadalia N, Nikbakht N. Shalabi D, et al. Dermatol Ther (Heidelb). 2019 Dec;9(4):807-814. doi: 10.1007/s13555-019-00317-2. Epub 2019 Aug 12. Dermatol Ther (Heidelb). 2019. PMID: 31407190 Free PMC article.
How to Sequence Therapies in Mycosis Fungoides.
Brumfiel CM, Patel MH, Puri P, Besch-Stokes J, Lester S, Rule WG, Khera N, Sluzevich JC, DiCaudo DJ, Comfere N, Bennani NN, Rosenthal AC, Pittelkow MR, Mangold AR. Brumfiel CM, et al. Curr Treat Options Oncol. 2021 Sep 27;22(11):101. doi: 10.1007/s11864-021-00899-0. Curr Treat Options Oncol. 2021. PMID: 34570278 Review.
Imiquimod as Local Immunotherapy in the Management of Premalignant Cutaneous Conditions and Skin Cancer.
Garcia-Mouronte E, Berna-Rico E, de Nicolas-Ruanes B, Azcarraga-Llobet C, Alonso-Martinez de Salinas L, Bea-Ardebol S. Garcia-Mouronte E, et al. Int J Mol Sci. 2023 Jun 29;24(13):10835. doi: 10.3390/ijms241310835. Int J Mol Sci. 2023. PMID: 37446011 Free PMC article. Review.
The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Current and future approaches.
Weiner DM, Durgin JS, Wysocka M, Rook AH. Weiner DM, et al. J Am Acad Dermatol. 2021 Mar;84(3):597-604. doi: 10.1016/j.jaad.2020.12.026. Epub 2020 Dec 22. J Am Acad Dermatol. 2021. PMID: 33352268 Free PMC article. Review.
New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma.
Fujii K. Fujii K. Front Oncol. 2018 Jun 4;8:198. doi: 10.3389/fonc.2018.00198. eCollection 2018. Front Oncol. 2018. PMID: 29915722 Free PMC article. Review.

References

1. Jawed S.I., Myskowski P.L., Horwitz S., Moskowitz A., Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol. 2014;70(2):205.e1–205.e16. quiz 221-2. - PubMed
1. Jawed S.I., Myskowski P.L., Horwitz S., Moskowitz A., Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): part II. Prognosis, management, and future directions. J Am Acad Dermatol. 2014;70(2):223.e1–223.e17. quiz 240-2. - PubMed
1. Olsen E.A. Interferon in the treatment of cutaneous T-cell lymphoma. Dermatol Ther. 2003;16(4):311–321. - PubMed
1. Sauder D.N. Immunomodulatory and pharmacologic properties of imiquimod. J Am Acad Dermatol. 2000;43(1 Pt 2):S6–S11. - PubMed
1. Huen A.O., Rook A.H. Toll receptor agonist therapy of skin cancer and cutaneous T-cell lymphoma. Curr Opin Oncol. 2014;26(2):237–244. - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

[1] Jawed S.I., Myskowski P.L., Horwitz S., Moskowitz A., Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol. 2014;70(2):205.e1–205.e16. quiz 221-2. - PubMed

[2] Jawed S.I., Myskowski P.L., Horwitz S., Moskowitz A., Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol. 2014;70(2):205.e1–205.e16. quiz 221-2. - PubMed

[3] Jawed S.I., Myskowski P.L., Horwitz S., Moskowitz A., Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): part II. Prognosis, management, and future directions. J Am Acad Dermatol. 2014;70(2):223.e1–223.e17. quiz 240-2. - PubMed

[4] Jawed S.I., Myskowski P.L., Horwitz S., Moskowitz A., Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): part II. Prognosis, management, and future directions. J Am Acad Dermatol. 2014;70(2):223.e1–223.e17. quiz 240-2. - PubMed

[5] Olsen E.A. Interferon in the treatment of cutaneous T-cell lymphoma. Dermatol Ther. 2003;16(4):311–321. - PubMed

[6] Olsen E.A. Interferon in the treatment of cutaneous T-cell lymphoma. Dermatol Ther. 2003;16(4):311–321. - PubMed

[7] Sauder D.N. Immunomodulatory and pharmacologic properties of imiquimod. J Am Acad Dermatol. 2000;43(1 Pt 2):S6–S11. - PubMed

[8] Sauder D.N. Immunomodulatory and pharmacologic properties of imiquimod. J Am Acad Dermatol. 2000;43(1 Pt 2):S6–S11. - PubMed

[9] Huen A.O., Rook A.H. Toll receptor agonist therapy of skin cancer and cutaneous T-cell lymphoma. Curr Opin Oncol. 2014;26(2):237–244. - PubMed

[10] Huen A.O., Rook A.H. Toll receptor agonist therapy of skin cancer and cutaneous T-cell lymphoma. Curr Opin Oncol. 2014;26(2):237–244. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Clearance of folliculotropic and tumor mycosis fungoides with topical 5% imiquimod

Affiliation

Clearance of folliculotropic and tumor mycosis fungoides with topical 5% imiquimod

Authors

Affiliation

Figures

Similar articles

Cited by

References

Publication types

LinkOut - more resources

Full Text Sources

Other Literature Sources